Cytokines in Rheumatoid Arthritis

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 1995 Sep 1

PMID 8846647

Citations 5

Authors

F A Houssiau

Affiliations

Soon will be listed here.

Abstract

An ever-growing number of cytokines that play a critical role as soluble mediators of immune and inflammatory responses are being described. Not surprisingly, most of them have been detected in SF or serum of patients with RA. However, given the numerous interactions within the cytokine network--e.g., agonistic and antagonistic properties and natural inhibitors--one should beware of over-simplistic views, the most so as extrapolation from in vitro and animal models is always a challenge. From a clinical viewpoint, more work is required before measurements of cytokines in RA be used as activity indices and--more importantly--as prognostic marker.

Citing Articles

Inflammation induced loss of skeletal muscle.

Londhe P, Guttridge D Bone. 2015; 80:131-142.

PMID: 26453502 PMC: 4600538. DOI: 10.1016/j.bone.2015.03.015.

Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis.

Lim D, Bae Y Rheumatol Int. 2011; 31(7):843-7.

PMID: 21327427 DOI: 10.1007/s00296-011-1818-x.

Alpinia galanga extracts downregulate interleukin-1β-induced matrix metalloproteinases expression in human synovial fibroblasts.

Pothacharoen P, Choocheep K, Phitak T, Pompimon W, Kongtawelert P In Vitro Cell Dev Biol Anim. 2010; 47(3):183-7.

PMID: 21132464 DOI: 10.1007/s11626-010-9375-2.

Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages.

Yam M, Abdul Hafid S, Cheng H, Nesaretnam K Lipids. 2009; 44(9):787-97.

PMID: 19655189 DOI: 10.1007/s11745-009-3326-2.

Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha.

Christopherson J, Munson E, England D, Croke C, Remington M, Molitor M Clin Diagn Lab Immunol. 2003; 10(1):44-52.

PMID: 12522038 PMC: 145283. DOI: 10.1128/cdli.10.1.44-52.2003.

References

Keffer J, Probert L, Cazlaris H, Georgopoulos S, KASLARIS E, Kioussis D . Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991; 10(13):4025-31. PMC: 453150. DOI: 10.1002/j.1460-2075.1991.tb04978.x. View

Ishimi Y, Miyaura C, Jin C, Akatsu T, Abe E, Nakamura Y . IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990; 145(10):3297-303. View

Miossec P . Cytokine abnormalities in inflammatory arthritis. Baillieres Clin Rheumatol. 1992; 6(2):373-92. DOI: 10.1016/s0950-3579(05)80180-3. View

Eastgate J, Symons J, Wood N, Grinlinton F, Di Giovine F, Duff G . Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet. 1988; 2(8613):706-9. DOI: 10.1016/s0140-6736(88)90185-7. View

Di Giovine F, Duff G . Interleukin 1: the first interleukin. Immunol Today. 1990; 11(1):13-20. DOI: 10.1016/0167-5699(90)90005-t. View

Dinarello C, Thompson R . Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today. 1991; 12(11):404-10. DOI: 10.1016/0167-5699(91)90142-G. View

Dubois C, Ruscetti F, Palaszynski E, FALK L, Oppenheim J, Keller J . Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J Exp Med. 1990; 172(3):737-44. PMC: 2188563. DOI: 10.1084/jem.172.3.737. View

Stimpson S, DALLDORF F, Otterness I, Schwab J . Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol. 1988; 140(9):2964-9. View

Barrera P, Boerbooms A, Janssen E, Sauerwein R, Gallati H, Mulder J . Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum. 1993; 36(8):1070-9. DOI: 10.1002/art.1780360807. View

10.

Houssiau F, Devogelaer J, Van Damme J, de Deuxchaisnes C, Van Snick J . Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988; 31(6):784-8. DOI: 10.1002/art.1780310614. View

11.

Eisenberg S, Evans R, Arend W, VERDERBER E, Brewer M, Hannum C . Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990; 343(6256):341-6. DOI: 10.1038/343341a0. View

12.

Elliott M, Maini R, Feldmann M, Charles P, Katsikis P, Brennan F . Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993; 36(12):1681-90. DOI: 10.1002/art.1780361206. View

13.

Turner M, Chantry D, Katsikis P, Berger A, Brennan F, Feldmann M . Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur J Immunol. 1991; 21(7):1635-9. DOI: 10.1002/eji.1830210708. View

14.

Lotz M, Guerne P . Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem. 1991; 266(4):2017-20. View

15.

Seckinger P, Zhang J, Hauptmann B, Dayer J . Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Proc Natl Acad Sci U S A. 1990; 87(13):5188-92. PMC: 54287. DOI: 10.1073/pnas.87.13.5188. View

16.

Keystone E, Snow K, Bombardier C, Chang C, Nelson D, Rubin L . Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum. 1988; 31(7):844-9. DOI: 10.1002/art.1780310704. View

17.

Saxne T, Palladino Jr M, Heinegard D, Talal N, Wollheim F . Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 1988; 31(8):1041-5. DOI: 10.1002/art.1780310816. View

18.

Malyak M, Swaney R, Arend W . Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils. Arthritis Rheum. 1993; 36(6):781-9. DOI: 10.1002/art.1780360607. View

19.

Moore K, OGarra A, de Waal Malefyt R, Vieira P, Mosmann T . Interleukin-10. Annu Rev Immunol. 1993; 11:165-90. DOI: 10.1146/annurev.iy.11.040193.001121. View

20.

Brandes M, Allen J, Ogawa Y, Wahl S . Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest. 1991; 87(3):1108-13. PMC: 329908. DOI: 10.1172/JCI115073. View